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PECULIARITIES OF SPIROMETRIC INDICES IN SCHOOLCHILDREN  
WITH BRONCHIAL ASTHMA, DEPENDING ON THEIR ATOPIC STATUS
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Bukovinian State Medical University
In article on based analysis of spirometric indicators was researched the peculiarities of nonspecific bronchial 
hyperreactivity depending on the atopic status of school-age children. To identify the degree of atopy 
anamnestic atopic status and skin allergic tests were used. Children with atopic asthma characterized by 
tendency to expressive bronchial lability mostly due to bronhodilation response to short-acting β2-agonists and 
expressive airway hyperresponsiveness to histamine. However the verification of atopic asthma phenotype 
in children with bronchial lability index and the index of bronchodilation was characterized by high specific 
with low sensitivity. So, use markers of nonspecific bronchial hyperreactivity to confirmation atopic asthma 
phenotype relative nonatopic makes sense only in combination with other clinical, laboratory and intsrumental 
indices that reflect the main characteristics of the disease.
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Formulation of the problem. According to official statistics the prevalence of asthma 
is 5-10% in children [1, p. 1-7; 2, р. 33-36]. Bron-
chial asthma and recurrent bronchitis occupy the 
leading place among chronic and recurrent respi-
ratory diseases in children age. Special importance 
of problem of these diseases gets in view of the 
provisions that recurrent respiratory diseases in 
children is the debut of chronic bronchopulmona-
ry pathology of adult period of life [3, р. 19-21; 
4, р. 175–185]. One of the important aspects of in-
adequate asthma control is determined by its phe-
notypic heterogeneity [5, р. 46–57; 6, р. 19–23], 
particular, age debut (asthma early and late on-
set), type of bronchial inflammation (eosinophilic 
and noneosinophilic), the speed of lower respirato-
ry tract obstruction (torpid and labile obstruction), 
response to basic therapy (steroid-sensitive and 
resistant asthma) [7, р. 627-634; 8, р. 46-57].
Analysis of recent research and publications. 
The heterogeneity of phenotypes is the starting 
point for new approaches to classification, research 
of development mechanisms to achieve asthma 
control in the foreseeable future. The final ap-
proach is the definition of new phenotypes based 
on fundamental pathophysiological mechanisms 
(conception of endotypes) to better predict future 
risks of inadequate control [9, р. 355–360]. The 
relationship between proportion atopic and nona-
topic phenotypes in the structure asthma morbid-
ity among children and the relationship between 
variants of inflammation and intensity of mani-
festations bronchial hyperresponsiveness remain 
currently contradictory. Numerous research show 
that nonatopic form of the disease currently oc-
cupy a prominent place and cause increasing of 
morbidity in contrast to atopic variants, especially 
in developing countries with insufficient economic 
level [10, р. 76-88; 11, р. 643-648; 12, р. 1043-1049].
Bold of unsolved aspects of the problem. The 
question of differentiation asthma phenotypes of 
childhood-determining the particular aspects of 
the disease and individual approaches to treat-
ment is a major controversial problems in allergol-
ogy [13, р. 57–60]. Clinical phenotypes of asthma 
are heterogeneous; their formation depends on the 
genetic and environmental influences and is de-
termined mostly by the interaction of cellular ele-
ments of the respiratory tract and immune system 
[14, р.1267–1274]. Currently phenotyping of disease 
occurs in the two areas: clinical, pathophysiological, 
molecular markers [15, р. 627–634] and variants of 
response to therapy [16, р. 327–334]. Since the asth-
ma classification provides for atopic and nonatopic 
forms [17, р. 1-17], it was expedient considered to 
analyze the indices, that reflect characteristic phe-
nomenon of disease as bronchial hyperreactivity in 
these phenotypes, due to evidence-based medicine.
The aim of the study was to evaluate the spi-
rometric indicies of nonspecific bronchial hyper-
reactivity in school-age children with atopic and 
nonatopic bronchial asthma phenotypes.
Material and methods. According to bioethics 
principles in pulmonary department of Regional 
Pediatric Clinical Hospital (Chernivtsi) were exam-
ined 64 children, suffering from bronchial asthma. 
To identify the degree of atopy anamnestic atopic 
status and skin allergic tests were used. Accord-
ing to a survey 38 children with atopic asthma 
phenotype formed first clinical group (1st), and 
the remaining 26 patients with nonatopic asthma 
joined the second (2nd) clinical group. For the main 
clinical features comparison group did not differ 
significantly. So, in 1st clinical group boys account-
ed for 28 (73,7%), in the comparison group boys 
accounted 14 persons (53,9%, p
φ
>0,05), the rural 
population accounted for 60,5% among children 
with atopic asthma phenotype and in the 2nd clin-
ical group were 73,1% (19 patients, pφ>0,05). The 
average age of representatives in 1st clinical group 
was 11,6±0,55, in the comparison group of children 
the average age was 12,0±0,68 years (p>0,05). 
Bronchial lability was determined according to 
recommendations [18, р. 22-23; 19, р. 882–889] by 
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assessing their response to dosed physical exer-
cise and short-acting β2-agonists inhalation (salbu-
tamol 200 mcg) followed by calculating the index 
of bronchial lability as the sum of the components, 
such as index of bronchospasm (IBS) and index of 
bronchodilation (IBD). A positive bronchodilation 
answer was considered with indicators IBD more 
than 12% [20, р. 1-68].
Research of bronchial hyperresponsiveness was 
performed using standardized spirometric inhaled 
histamine test [21, р. 1-51] considering of recom-
mendations for standardization of study [22, р. 
3-96]. Indices of provocative concentration of his-
tamine to cause 20% fall in FEV1 (PC20H) and 
provocative dose of histamine (PD20H) used to de-
termine the airway hypersensitivity. In the study 
considered that the lower indices mean the higher 
histamine hypersensitivity [23, р. 38–42]. During 
bronhoprovocation test with dosed physical exer-
cise in a patient of 2nd clinical group airway wheez-
ing symptoms were recorded, and the patient was 
eliminated from further study.
Statistical analysis received data was performed 
with biostatistics position [24, р. 253-345]. To assess 
the diagnostic value of tests was determined the 
sensitivity, specificity, positive and negative pre-
dictive value with defined confidence intervals 
(95% CI) and likelihood ratio of test results. Risk 
assessment implementation of events was held 
considering of probability values relative risk, odds 
ratio and posttest probability, as well as their con-
fidence intervals [25, р. 98-132].
The main material. Table 1 shows the perfor-
mance of bronchial lability in children of compar-
ing groups in response to dosed physical exercise 
and inhalation of salbutamol (іndex of bronchodi-
lation) and the average value of the integral bron-
chial lability index (bronchial lability index).
A tendency to more severe lability was ob-
served in children with atopic asthma phenotype, 
mainly due to significant dilatation in response to 
short-acting β2-agonists inhalation. Thus, a positive 
test with short-acting β2-agonists was observed in 
42,1% children of the 1st clinical group and only in 
28% children in the comparison group (pφ>0,05).
Expressive airways dilated reaction (bronchial 
lability index more than 20%) inherent in every 
fifth patient with atopic asthma (21,1%) and for 
only 4% of children with nonatopic asthma phe-
notype (pφ<0,05). Thus, the index of bronchodila-
tion with values over 20% pointed to the relative 
risk of atopic phenotype of 1,9 (95% CI 0,2-13,9) at 
17,4 odds ratio (95% CI 2,1-142,1). Posttest prob-
ability of atopic asthma verification due to these 
values of bronchodilation index increased on 41%. 
Low indexes (bronchospasm and bronchodilation 
indexes) mainly were inherent in representatives of 
2nd clinical group. In particular, the increase in forced 
expiratory volume in 1st second less than 12% after 
salbutamol inhalation was observed in 2/3 of chil-
dren with nonatopic asthma phenotype and only in 
52,1% of the 1st clinical group (pφ>0,05). Minimum 
bronchospasm reaction in response to dosed physical 
exercise (index of bronchospasm less than 10%) was 
recorded significantly more often in patients with 
atopic asthma phenotype (60,5%) relative to the com-
parison group (36%; Pφ<0,05). Paradoxically dilated 
response to dosed physical exercise was observed in 
10,5% children of 1st clinical group. Thus, index of 
bronchospasm with values above 10% testified rela-
tive risk of atopic phenotype of 1,4 (95% CI 0,7-2,5) 
with 2,2 odds ratio (95% CI 0,7-6,5). Posttest prob-
ability of atopic phenotype detection with index of 
bronchospasm above 10% increased only on 10%.
Since the bronchial lability index is an integral 
index and displays the total bronchial response to 
dosed physical exercise and inhalation of salbu-
tamol, its expressive value proved in children with 
atopic asthma phenotype. In particular, high lability 
of the bronchi (bronchial lability index more than 
20%) was observed more than half of the represen-
tatives of 1st clinical group (52,6%) and only in 40% of 
children with nonatopic asthma (pφ>0,05). Expres-
sive bronchial lability (bronchial lability index more 
than 30%) also recorded more frequently among 
patients with atopic disease phenotype, particularly 
in every fourth person (26,3%), compared with rep-
resentatives of 2nd clinical group (16%; pφ>0,05). In 
accordance expressive bronchial lability pointed to 
relative risk of atopic asthma 1,2 (95% CI 0,4-3,5) 
Table 1
Indices of bronchial lability in clinical groups of schoolchildren (M±m)







І Children with atopic asthma 38 11,4±1,7 11,8±1,9 23,2±2,7
ІІ Children with nonatopic asthma 25 10,5±1,7 7,6±1,9 18,1±2,8
p >0,05 >0,05 >0,05
Note. P – probability criterion of Student
Origin: developed by the author
Table 2
Diagnostic value indices of nonspecific bronchial hyperreactivity in confirming atopic asthma
Bronchial lability and hyperresponsiveness 
indices
Diagnostic value, % Likelihood ratio




Index of bronhodilation >20% 42 96 94 52 10,5 0,6
Index of bronhospasm >10% 55 64 67 51 1,5 0,6
Bronchial lability index > 30% 26 84 71 42 1,6 0,8
PC20H<0,6 mg/mL 60 72 76 54 2,1 0,5
Note. PC20H – provocative concentration of histamine.
Origin: developed by the author













with 1,8 odds ratio (95% CI 0,5-6,8). Posttest prob-
ability of atopic asthma verification in these values 
of lability index increased less than 12%.
During analysis of bronchial hyperresponsive-
ness the tendency to expressive of this phenome-
non was established in children with atopic asthma 
phenotype. In particular, PC20H was 1,3±0,3 mg/
ml in patients of 1st group versus 2,2±0,8 mg/ml 
representatives of comparison group (p>0,05).
Expressive bronchial hyperresponsiveness 
(PC20H<0,6 mg/mL) was observed in almost 2/3 
of patients of 1st clinical group (60,5%) and only in 
28% of children of the comparison group (pφ>0,05), 
and pointed to the relative risk of atopic asth-
ma 1,6 (95% CI 0,8-3,3) with 3,9 odds ratio (95% 
CI 1,3-11,7). Posttest probability of atopic asthma 
phenotypes detection with expressive hyperres-
ponsiveness increased only on 18%.
Informativeness of bronchial lability and hy-
perresponsiveness indices in the confirmation of 
atopic disease phenotype relative nonatopic asth-
ma is shown in Table 2.
Bronchial lability and hyperresponsiveness 
indices in confirming atopic asthma relatively 
nonatopic phenotype of the disease proved to 
enough specific with a significant proportion of 
false negative results.
Conclusions and suggestions. 1. Children with 
atopic asthma characterized by tendency to ex-
pressive bronchial lability mostly due to bronhodi-
lation response to short-acting β2-agonists and ex-
pressive airway hyperresponsiveness to histamine.
2. In selected distribution points bronchial labil-
ity indices, including integral index and bronchodi-
lation index, characterized by sufficient specificity 
(84% and 96%, respectively) for the verification of 
atopic asthma phenotype in children.
3. Use markers of nonspecific bronchial hy-
perreactivity to confirmation atopic asthma phe-
notype relative nonatopic makes sense only in 
combination with other clinical, laboratory and 
intsrumental indices that reflect the main char-
acteristics of the disease.
Prospects for future research consist in identi-
fying in children with atopic and nonatopic asthma 
phenotypes markers of activity of airway inflam-
mation and evaluation of diagnostic and prognostic 
value of these markers.
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ОСОБЛИВОСТІ СПІРОМЕТРИЧНИХ ПОКАЗНИКІВ У ШКОЛЯРІВ,  
ХВОРИХ НА БРОНХІАЛЬНУ АСТМУ, ЗАЛЕЖНО ВІД ЇХ АТОПІЧНОГО СТАТУСУ
Анотація
У статті на основі аналізу у дітей шкільного віку спірометричних показників досліджено особливості 
неспецифічної гіперреактивності бронхів залежно від атопічного статусу пацієнтів. Для виявлення 
міри атопії використовували дослідження анамнестичного атопічного статусу та показники шкірних 
реакцій негайного типу із стандартними небактеріальними аероалергенами. Встановлено, що в дітей, 
хворих на атопічну бронхіальну астму характерною є тенденція до виразнішої лабільності бронхів, 
здебільшого, за рахунок бронходилятаційної реакції на β2-адреноміметик короткої дії, а також 
виразніша гіперcприйнятливість дихальних шляхів до гістаміну. Водночас, у верифікації атопічного 
фенотипу бронхіальної астми у дітей показник лабільності бронхів та індекс бронходилятації вия-
вилися специфічними, проте низькочутливими. Таким чином, використання маркерів неспецифічної 
гіперреактивності бронхів у підтвердженні атопічної БА відносно неатопічного фенотипу захворюван-
ня є доцільним лише в комплексі з іншими клінічними та лабораторно-інтсрументальними показника-
ми, які відображають основні характеристики захворювання.
Ключові слова: бронхіальна астма, діти, атопія, фенотип, гіперреактивність бронхів.
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ОСОБЕННОСТИ СПИРОМЕТРИЧЕСКИХ ПОКАЗАТЕЛЕЙ  
У ШКОЛЬНИКОВ, БОЛЬНЫХ БРОНХИАЛЬНОЙ АСТМОЙ,  
В ЗАВИСИМОСТИ ОТ ИХ АТОПИЧЕСКОГО СТАТУСА
Аннотация
В статье на основе анализа у детей школьного возраста спирометрических показателей исследова-
ны особенности неспецифической гиперреактивности бронхов в зависимости от атопического статуса 
пациентов. Для выявления степени атопии использовали исследования анамнестического атопическо-
го статуса и показатели кожных реакций немедленного типа со стандартными небактериальными 
аэроаллергенами. Установлено, что у детей, больных атопической бронхиальной астмой, характерна 
тенденция к выраженой лабильности бронхов, в основном, за счет бронходилятационной реакции на 
β2-адреномиметик короткого действия, а также выраженная гипервосприимчивость дыхательных пу-
тей к гистамину. В то же время, в верификации атопического фенотипа бронхиальной астмы у де-
тей показатель лабильности бронхов и индекс бронходилятации оказались специфическими, однако 
низкочувствительными. Таким образом, использование маркеров неспецифической гиперреактивности 
бронхов в подтверждении атопической бронхиальной астмы относительно неатопического фенотипа 
заболевания целесообразно лишь в комплексе с другими клиническими и лабораторно-интсрументаль-
ными показателями, которые отражают основные характеристики заболевания.
Ключевые слова: бронхиальная астма, дети, атопия, фенотип, гиперреактивность бронхов.
